Together, the three tests cover nearly 5000 genes and 17 tissue types – representing 69 morphologies and covering 95% of solid tumors – to identify the tissue of origin.
Based on results from the Tissue of Origin Test, the Tissue of Origin Endometrial Test and the Tissue of Origin Head & Neck Test will be ordered by the CGI pathologist as needed to pinpoint the tumor of origin.
The most validated, most accurate and most published testing service offers THREE Tissue of Origin tests that use a tumor’s genomic information to help identify its origin in challenging cases:
Tissue of Origin Testing Service
|Description||Number of Validation Specimens||Published Accuracy*|
|Tissue of Origin||FDA-cleared, 2,000 genes, 15 tissue types||462||89%|
|Tissue of Origin Endometrial||375 genes; distinguishes Endometrial from Ovarian||75||95%|
|Tissue of Origin
Head & Neck
|2,600 genes differentiate NSCLS from HN, when morphology is squamous||76||83%|